Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of THB 7.37 trillion. The enterprise value is 7.78 trillion.

Market Cap	7.37T
Enterprise Value	7.78T

Important Dates

The last earnings date was Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.57%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.19B

Valuation Ratios

The trailing PE ratio is 12.98 and the forward PE ratio is 12.16.

PE Ratio	12.98
Forward PE	12.16
PS Ratio	4.62
PB Ratio	8.58
P/TBV Ratio	23.95
P/FCF Ratio	22.11
P/OCF Ratio	11.87
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.51, with an EV/FCF ratio of 23.33.

EV / Earnings	13.70
EV / Sales	4.90
EV / EBITDA	9.51
EV / EBIT	10.28
EV / FCF	23.33

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.59.

Current Ratio	0.78
Quick Ratio	0.50
Debt / Equity	0.59
Debt / EBITDA	0.62
Debt / FCF	1.52
Interest Coverage	17.27

Financial Efficiency

Return on equity (ROE) is 79.17% and return on invested capital (ROIC) is 42.53%.

Return on Equity (ROE)	79.17%
Return on Assets (ROA)	21.82%
Return on Invested Capital (ROIC)	42.53%
Return on Capital Employed (ROCE)	54.12%
Revenue Per Employee	20.35M
Profits Per Employee	7.24M
Employee Count	77,349
Asset Turnover	0.73
Inventory Turnover	1.20

Taxes

In the past 12 months, Novo Nordisk has paid 151.91 billion in taxes.

Income Tax	151.91B
Effective Tax Rate	21.10%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	2.18
200-Day Moving Average	2.77
Relative Strength Index (RSI)	36.78
Average Volume (20 Days)	7,351,548

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of THB 1.59 trillion and earned 567.89 billion in profits. Earnings per share was 127.59.

Revenue	1.59T
Gross Profit	1.34T
Operating Income	759.99B
Pretax Income	719.80B
Net Income	567.89B
EBITDA	814.30B
EBIT	759.99B
Earnings Per Share (EPS)	127.59

Full Income Statement

Balance Sheet

The company has 96.81 billion in cash and 507.56 billion in debt, giving a net cash position of -410.75 billion.

Cash & Cash Equivalents	96.81B
Total Debt	507.56B
Net Cash	-410.75B
Net Cash Per Share	n/a
Equity (Book Value)	859.32B
Book Value Per Share	193.39
Working Capital	-229.15B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 621.37 billion and capital expenditures -287.88 billion, giving a free cash flow of 333.49 billion.

Operating Cash Flow	621.37B
Capital Expenditures	-287.88B
Free Cash Flow	333.49B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 84.26%, with operating and profit margins of 47.65% and 35.61%.

Gross Margin	84.26%
Operating Margin	47.65%
Pretax Margin	45.13%
Profit Margin	35.61%
EBITDA Margin	51.06%
EBIT Margin	47.65%
FCF Margin	20.91%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 1.68%.

Dividend Per Share	0.03
Dividend Yield	1.68%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	45.63%
Buyback Yield	0.57%
Shareholder Yield	2.25%
Earnings Yield	7.70%
FCF Yield	4.52%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novo Nordisk has an Altman Z-Score of 7.82 and a Piotroski F-Score of 4.

Altman Z-Score	7.82
Piotroski F-Score	4